Which gene is associated with vascular dementia among Amyloid Precursor Protein (APP), Tau protein, Ubiquitin, Notch 3, and Alpha Synuclein?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NOTCH3 Gene is Associated with Vascular Dementia

Among the listed genes, NOTCH3 is the gene most strongly associated with vascular dementia. 1

Evidence for NOTCH3 and Vascular Dementia

NOTCH3 mutations are responsible for Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), which is a well-established genetic cause of vascular dementia. According to the 2024 American Heart Association/American Stroke Association guidelines, CADASIL is characterized by:

  • Lacunar strokes typically presenting in the 6th decade
  • Cerebral microhemorrhages
  • Migraine with aura
  • Dementia
  • Pseudobulbar affect 1

The 2006 National Institute of Neurological Disorders and Stroke-Canadian Stroke Network guidelines specifically identify NOTCH3 as being associated with vascular cognitive impairment, stating that "VCI has been recognized as a clinically important problem in CADASIL (NOTCH3)" 1.

Comparison with Other Listed Genes

  1. Amyloid Precursor Protein (APP): Primarily associated with Alzheimer's disease and cerebral amyloid angiopathy, not specifically with vascular dementia 1.

  2. Tau Protein: Primarily associated with Alzheimer's disease, frontotemporal dementia, and other tauopathies. The 2006 guidelines specifically note that "Tau and phospho-tau are negative markers that are elevated in the CSF in AD, but not in VCI [Vascular Cognitive Impairment]" 1.

  3. Ubiquitin: While involved in protein degradation pathways relevant to many neurodegenerative diseases, it is not specifically linked to vascular dementia in the guidelines.

  4. Alpha Synuclein: Primarily associated with Parkinson's disease, Lewy body dementia, and multiple system atrophy, not specifically with vascular dementia.

Clinical Relevance of NOTCH3 in Vascular Dementia

NOTCH3 mutations lead to CADASIL, which:

  • Is the most prominent known cause of inherited stroke and vascular dementia in adults 2
  • Results in dementia in over 80% of cases 3
  • Causes small vessel disease affecting brain arteries 2
  • Leads to accumulation of NOTCH3 extracellular domain at smooth muscle cell plasma membranes 2

The 2020 American College of Radiology guidelines note that in patients with CADASIL, "MRI in these patients helps to suggest the diagnosis by showing characteristic hyperintense T2 or fluid-attenuated inversion recovery lesions, which predominate in the frontal, parietal, and anterior temporal cortexes and in the external capsule" 1.

Diagnostic Considerations

When vascular dementia is suspected:

  • Genetic testing for NOTCH3 mutations should be considered, especially in patients with:
    • Family history of stroke or dementia
    • Early-onset vascular dementia
    • White matter changes on brain imaging
    • History of migraine with aura
  • Diagnosis can be confirmed by skin biopsy or detection of pathogenic NOTCH3 mutations 1

While other genetic factors may contribute to vascular dementia risk, NOTCH3 mutations represent the most clearly established genetic cause of vascular dementia among the genes listed in the question.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

CADASIL syndrome: a genetic form of vascular dementia.

Journal of geriatric psychiatry and neurology, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.